The MLL partial tandem duplication in adults aged 60 years and older with de novo cytogenetically normal acute myeloid leukemia

Ítems similars

• A stem cell-like gene expression signature associates with inferior outcomes and a distinct microRNA expression profile in adults with primary cytogenetically normal acute myeloid leukemia
  per: Metzeler, KH, et al.
  Publicat: (2013)
• Low expression of MN1 associates with better treatment response in older patients with de novo cytogenetically normal acute myeloid leukemia
  per: Schwind, Sebastian, et al.
  Publicat: (2011)
• RUNX1 Mutations Are Associated With Poor Outcome in Younger and Older Patients With Cytogenetically Normal Acute Myeloid Leukemia and With Distinct Gene and MicroRNA Expression Signatures
  per: Mendler, Jason H., et al.
  Publicat: (2012)
• Age-Related Prognostic Impact of Different Types of DNMT3A Mutations in Adults With Primary Cytogenetically Normal Acute Myeloid Leukemia
  per: Marcucci, Guido, et al.
  Publicat: (2012)
• ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic category
  per: Metzeler, Klaus H., et al.
  Publicat: (2011)